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Concomitant chronic diseases are a common ﬁnding in clinics and may consist in a major issue in ther-
apeutics. Here, we investigated whether prolonged ingestion of ovalbumin (Ova) by sensitized mice
would reduce the severity of an associated concurrent immunomediated condition such as antigen-
induced arthritis (AIA). AIA was induced by administration of methylated bovine albumin (mBSA) into
the knee joints of previously immunized mice, and evaluated by articular leukocyte trafﬁcking and levels
of cytokines (TNF-a, IL-1b) and chemokine (CXCL-1) in the periarticular tissue. Continuous Ova feeding
by Ova sensitized mice decreased serum levels of anti-Ova IgE, and led to a signiﬁcant suppression of leu-
kocyte adhesion and inﬁltration into synovial tissue and cavity. Also, a marked cytokine reduction was
observed, suggesting that prolonged ingestion of ovalbumin by sensitized mice suppresses speciﬁc IgE
production with concomitant reduction in peripheral T cells, which may impact in the pathogenesis of
AIA, a non-related condition.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Dietary proteins and products from gut microbiota constantly
activate physiological interactions among immune cells and these
molecules [1–3]. It is estimated that 100 kg of proteins may pass
through the gut of an adult human being every year without caus-
ing detectable adverse reactions [4]. Such untroubled relationship
may be explained by a phenomenon named ‘‘oral tolerance to die-
tary proteins’’, and it usually refers to how a prior ingested antigen
modulates the systemic immune responses to an antigenic chal-
lenge given by a parenteral route [5]. On the other hand, it is wellaccepted that the breakdown or the absence of oral tolerance
might trigger food allergy reactions [4].
Food allergies are disorders that affect about 20–30% of the hu-
man population in developing countries, making them one of the
most common chronic diseases [6]. It is generally accepted that
6–8% of all children below three years old present food allergy
reactions [7,8], specially IgE-mediated hypersensitivities [9]. The
most common foods associated to allergy episodes are milk, egg,
peanut, chestnut and shrimp [7,10]. In atopic patients, involuntary
exposure to a food allergen may induce a mild and persistent aller-
gic condition involving disorders of skin, gastrointestinal and
respiratory tracts, or trigger a multi-organ systemic reaction with
cardiovascular collapse [11]. Therefore, there is a considerable
interest in identifying therapies directed to prevent or reduce food
allergy-related morbidity.
Oral immunotherapy (OIT) is one of these interventions and in-
volves the regular administration of small amounts of allergen by
the oral route in order to ﬁrst rapidly induce desensitization and
then induce tolerance to the allergen [12]. Recently, it has been
shown that the OIT protocols are efﬁcient as treatment of allergies
to cow’s milk, egg, ﬁsh and fruits [13,14]. However, little is known
regarding to the effect of OIT in non related pathological conditions.
For example, homing of immune cells from the gut to the inﬂamed
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arthritis [15] and it is reasonable to propose that the immune reg-
ulation of one pathological condition may affect the other one.
Rheumatoid arthritis (RA) is an autoimmune inﬂammatory dis-
ease that affects the synovial tissue within joints, typically the
small joints of the hands and feet [16]. RA affects between 0.3%
and 1% of the general population and it is more common in middle
age. In general, RA results in persistent pain and stiffness, progres-
sive joint destruction, functional decline and premature death [16],
and the available therapies usually fail in promote satisfactory re-
sults [17]. The pathological outcome of inﬂammatory arthritis is
governed by the presence of the cytokines TNF-a, IL-1b and che-
mokine CXCL-1 in the synovium, which activate resident cells to
attract neutrophil sinto the synovial cavity, amplifying the inﬂam-
matory response. In fact, these inﬂammatory events are observed
in the murine model of antigen-induced arthritis (AIA) in a similar
manner to human rheumatoid arthritis [18–22].
Considering that concomitant chronic diseases are a major chal-
lenge in therapeutics, the aim of this study was to investigate
whether the continuous ingestion of ovalbumin (Ova) by Ova-sen-
sitized mice could trigger oral tolerance and dampen the develop-
ment of antigen-induced arthritis.2. Materials and methods
2.1. Mice
Male BALB/c mice (6–8 weeks old)were used. Mice were ob-
tained from the animal facility at ICB/UFMG. All mice received
standard (Purina) mouse chow until the Ova diet consumption.
The investigations were consistent with the Ethical Principles in
Animal Experimentation, adopted by the Ethics Committee in Ani-
mal Experimentation of our Institution (protocol 191/2007-CETEA/
UFMG).
2.2. Ova sensitization and oral ingestion
The Control group received 0.2 ml saline (0.9%) with adjuvant
[1 mg Al(OH)3] on day 0 and saline on day 14. The Ova group re-
ceived 0.2 ml saline (0.9%) with adjuvant and 10 lg Ova (ﬁve times
crystallized hen’s egg albumin; Sigma, St. Louis, MO, USA) on day 0
and saline with 10 lg Ova on day 14. All injections were performed
subcutaneously. Seven days after the booster (day 21), the stan-
dard chow of all groups was replaced with 14% Ova diet for a per-
iod of one or two weeks (from day 21 until the end of the
experiment) (Fig. 1A). This diet was prepared using a lyophilized
egg white (Salto’s, Belo Horizonte, MG, Brazil) and nutrient con-
tents were the same speciﬁed for AIN-93G [23]. During the period
of Ova diet, food consumption was assessed daily by weighting the
remaining chow, in the cage of ﬁve mice, and comparing its weight
with the previous day. Data were reported as percentage of diet
consumption (Ova group/Control group), considering diet con-
sumption by Control group as 100%.
In another set of experiments, some mice received the same
sensitization with Ova described above and were fed with Ova diet
only for 24 h on day 21. Other groups were not sensitized or fed
with the antigen. All these additional groups are speciﬁed in the re-
lated ﬁgures (Fig. 7A and B).
2.3. Arthritis induction
In another set of experiments mice were separated in four
groups (Control, Arthritis, Ova, Ova/Arthritis). Ova and Ova/Arthri-
tis groups received the Ova sensitization described before and the
Control and Arthritis group received only the adjuvant [Al(OH)3].On day 21, the standard mouse chow (Purina, Belo Horizonte,
MG, Brazil) was replaced with a 14% Ova diet for all groups until
the end of the experiments.
Also on day 21, the Arthritis and Ova/Arthritis groups were in-
tra-dermally immunized at the base of the tail with 500 lg of
methylated bovine serum albumin (mBSA; Sigma, St. Louis, MO)
in 100 ll of an emulsion of saline and an equal volume of Freund’s
complete adjuvant (CFA; Sigma). The Control and Ova groups re-
ceived only 100 ll of an emulsion of saline and an equal volume
of Freund’s complete adjuvant. Fourteen days later (day 35), each
mouse in Arthritis and Ova/Arthritis groups received an injection
of 10 lg of mBSA (in 10 ll sterile saline) in both knee joint and
in Control and Ova groups they received only 10 ll of sterile saline
in both knee joint. Details of each experimental group are de-
scribed in Fig. 2A.
2.4. Intravital microscopy of the synovial microcirculation
Intravital microscopy was performed in the synovial microcir-
culation of the mouse knee, as described previously [19]. Brieﬂy,
the left hind limb was placed on a stage, with the knee slightly
ﬂexed and the patellar tendon mobilized and partly resected. The
intra-articular synovial tissue of the knee joint was then visualized
for the determination of leukocyte rolling and adhesion.
A 20-fold objective was used to select 2–4 regions of interest in
each mouse. To measure the leukocyte–endothelial cell interac-
tions, the ﬂuorescent marker rhodamine 6 G (Sigma) was injected
intravenously as a single bolus of 0.15 mg/kg immediately before
the measurements. Rhodamine epiilumination was achieved with
a 150 W variable HBOmercury lamp in conjunction with a Zeiss ﬁl-
ter set 15 (546/12 nm band-pass ﬁlter, 580 nm Fourier transforms,
590 nm late potentials; Zeiss, Wetzlar, Germany). The microscopic
images were captured with a video camera (5100 HS; Panasonic,
Secaucus, NJ) and recorded on S-VHS videotape, using both ﬁlter
blocks consecutively. Data analysis was performed off-line.
Rolling leukocytes were deﬁned as those cells moving slower
than the cells moving at a regular ﬂux in a given vessel. The ﬂux
of rolling cells was measured as the number of rolling cells passing
by a given point in the venule per minute, with results expressed as
cells/minute. A leukocyte was considered to be adherent if it re-
mained stationary for at least 30 s, and total leukocyte adhesion
was quantiﬁed as the number of adherent cells within a 100 lm
length of venule, with results expressed as cells/100 lm.
2.5. Serum and tissue collection
At the end of the experimental protocol, all groups were deeply
anesthetized by intraperitoneal injection (i.p.) of 10 mg/kg xyla-
zine and 100 mg/kg ketamine hydrochloride and blood samples
were obtained from the axillary plexus for anti-Ova IgE and
anti-mBSAIgG assays. Next, the animals were euthanized by i.p.
injection of more of the same anesthetic solution and knee synovial
cavity lavage was performed. The periarticular tissue of the left
knee was removed for evaluation of myeloperoxidase activity
and the levels of cytokines (TNF-, IL-1) and chemokine (CXCL-1).
2.6. Determination of absolute peripheral T cell count
For quantiﬁcation and phenotyping of T cells, heparinized anti-
coagulated blood was lysed using ACKlysis buffer. Specimens were
then counted and 106 cells/mouse were labeled with anti-CD3 PE-
Cy7, anti-CD4 FITC, anti-CD25 APC anti-CD8 PerCPor their respec-
tive isotype controls (BD Biosciences). Intracellular staining for
Foxp3 was performed with ﬁxation/permeabilization kit according
to the manufacturer’s protocol (BD Biosciences) and detected with
anti-Foxp3 PE (BD Biosciences). Data were acquired with a BD
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Fig. 1. Experimental protocol, kinetics of diet consumption, kinetics of speciﬁc serum IgE levels and quantiﬁcation of peripheral T cells. (A) BALB/c mice of Ova group were
sensitized with ovalbumin (Ova) in Al(OH)3 on day 0 and with Ova on day 14. The Control group received Al(OH)3 on day 0 and saline on day 14. On day 21, the standard
mouse chow was replaced by Ova diet for both groups until the end of experiment (day 35). (B) Food intake was assessed every day from day 21 to day 35 and the data was
reported as percentage of diet consumption (Ova group/Control group). (C) On days 1, 3, 7 and 14, serum of sensitized mice was collected for anti-Ova IgE measurement by
ELISA. On days 7 and 14 whole blood of sensitized mice was collected for quantiﬁcation of peripheral CD3+ CD4+ cells (D), CD3+ CD8+ cells (E) and CD3+ CD4+ CD25+ Foxp3+
cells (F). Values represent the mean ± SEM. ⁄p < 0.05 compared to Control group. ⁄⁄p < 0.05 compared to 1, 3 and 14 days of Ova consumption.
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CD3+ CD8+ and CD3+ CD4+ CD25+ Foxp3+ cells were determined
in the lymphocyte gate, deﬁned in terms of light-scattering proper-
ties, using FlowJo software (TreeStar, Inc. Ashland, OR). Absolute
counts were calculated from the absolute blood count.2.7. Knee synovial cavity lavage
The left knee synovial cavity was washed with phosphate buf-
fered saline (PBS) (2  5 ll), and the total number of leukocytes
in the cavity lavage was determined by counting the leukocytes
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Fig. 2. Experimental protocol of arthritis induction and evaluation of speciﬁc serum IgE and IgG levels. (A) BALB/c mice of Ova and Ova/Arthritis groups were sensitized with
ovalbumin (Ova) in Al(OH)3 on day 0 and with Ova on day 14. The Control and Arthritis groups received Al(OH)3 on day 0 and saline on day 14. On day 21 the Arthritis and
Ova/Arthritis groups were immunized with mBSA in Freund’s complete adjuvant (CFA) and the Control and Ova groups received only an emulsion of saline in CFA. On the
same day (day 21), the standard mouse chow was replaced by Ova diet for all groups until the end of experiment (day 36). On day 35, the Arthritis and Ova/Arthritis groups
received an injection of mBSA in saline in both knee joint while the Control and Ova groups received only saline. On day 36, serum was collected for anti-Ova IgE (B) and anti-
mBSA IgG (C) measurements by ELISA. Values represent the mean ± SEM. ⁄p < 0.05 compared to Control group. ⁄⁄p < 0.05 compared to Arthritis group.
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Differential counts were obtained from cytospin preparations
(Shandon III; Thermo Shandon, Frankfurt, Germany) by evaluating
the percentage of each leukocyte on a slide stained with May–
Grunwald–Giemsa stain.
2.8. Histological analysis
The right knee joint was removed and ﬁxed for 48 h with 10%
paraformaldehyde (pH 7.2). The joints were then incubated in 10%
EDTA at pH 7.2 for 20 days at room temperature to decalcify the
bone. Samples were washed with PBS and dehydrated. After being
embedded in parafﬁn, the jointswere sliced into 3 lm-thick sections
thatwere stainedwith hematoxylin and eosin (H&E). The slideswere
evaluated qualitatively using various parameters, as follows: sever-
ity of synovial hyperplasia (pannus formation), cellular exudate, car-
tilage depletion/bone erosion and extent of synovial inﬁltrate.
2.9. Determination of myeloperosidase (MPO) activity
The periarticular tissue of the left knee joint was removed after
knee cavity lavage and frozen at 70 C. Upon thawing of the
sample, the tissue (0.1 mg of tissue per 1.9 ml of buffer) washomogenized and processed for determination of MPO activity.
The assay included 25 ll of 3,3–5,5-tetramethylbenzidine (Sigma)
in PBS (pH 5.4) as the color reagent [22].
2.10. Enzyme-linked immunosorbent assay (ELISA) measurements
Levels of anti-Ova IgE were evaluated by capture-ELISA using
plates coated with rat anti-mouse IgE, 50 ll total serum and biotin-
ylated Ova, as previously described [24]. The results for anti-Ova
IgE antibodies were reported in arbitrary units (A.U.) using a highly
positive reference serum determined as 1000 units. The ELISA test
for anti-mBSAIgGwas carried out using plates coatedwith 2 lg/well
of methylated bovine serum albumin (mBSA; Sigma, St. Louis, MO),
100 ll of a 1:400 dilution of mouse sera, rabbit anti-mouse IgG
(H + L)-HRP (Southern Biothecnology Associates, Birmingham, AL,
USA). The reaction for anti-mBSAIgG was developed with O-pheny-
lene-diamine and H2O2. The plates were read at 492 nm on an auto-
mated ELISA reader (Expert Plus, AsysHitech GMBH, Eugendorf,
Austria). The concentrations of cytokines TNF-a and IL-1b and the
chemokines CXCL1 were measured in the periarticular tissue of left
knee using a commercially available enzyme-linked immunosorbent
assay, following the instructions supplied by themanufacturer (Duo-
Set kits; R&D Systems, Minneapolis, MN). Brieﬂy, 100 mg of tissue
Fig. 3. TNF-a, IL-1 and CXCL-1 levels in periarticular tissue. BALB/c mice of Ova and
Ova/Arthritis groups were sensitized with ovalbumin (Ova) in Al(OH)3 on day 0 and
with Ova on day 14. The Control and Arthritis groups received Al(OH)3 on day 0 and
saline on day 14. On day 21, the Arthritis and Ova/Arthritis groups were immunized
with mBSA in Freund’s complete adjuvant (CFA) and the Control and Ova groups
received only an emulsion of saline in CFA. On the same day (day 21), the standard
mouse chow was replaced by Ova diet for all groups until the end of experiment
(day 36). On day 35, the Arthritis and Ova/Arthritis groups received an injection of
mBSA in saline in both knee joint while the Control and Ova groups received only
saline. On day 36, the periarticular tissue of left knee joint was collected and
assayed for TNF-a (A), IL-1b (B) and CXCL-1 (C) levels by ELISA. Values represent the
mean ± SEM. p < 0.05 compared to Control group. ⁄⁄p < 0.05 compared to Arthritis
group.
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phenylmethylsulfonyl ﬂuoride, 0.1 mM benzethonium chloride,
10 mM EDTA, and 20 kallikrein inhibitor units of aprotinin A) and
0.05% Tween 20. The samples were then centrifuged for 10 min at
3000g and the supernatants were immediately assessed by ELISA at
a 1:3 dilution in PBS. All samples were assayed in duplicate.
2.11. Statistical analysis
All values were expressed as mean ± SEM. Parametric data were
evaluated using analysis of variance, followed by the Tukey test for
multiple comparisons. Differences were considered statistically
signiﬁcant at p < 0.05. The GraphPad Prism software was used.
3. Results
3.1. Kinetics of Ova diet consumption, speciﬁc serum antibody levels
and CD4+, CD8+, CD4+CD25+Foxp3+ blood cells in Ova sensitized mice
after continuous Ova diet feeding
Analysis of Ova diet consumption and serum anti-Ova IgE levels
were performed after 1, 3, 7 and 14 days of continuous and re-
stricted Ova diet consumption by Ova sensitized (Ova group) and
non-sensitized mice (Control group) (Fig. 1A). Ova immunized
mice displayed a continuous decrease in Ova diet consumption
comparing to the Control group until the seventh day of Ova diet
exposure. In contrast after this time, the aversion of Ova diet was
abrogated and mice from Ova group showed higher food consump-
tion in comparison to the Control group (Fig. 1B). The serum anti-
Ova IgE levels were increased in immunized mice in all days, de-
spite the highest level was observed on day 7, in which the aver-
sive behavior was more evident. On day 14, the serum anti-Ova
IgE levels were similar to the ﬁrst days of Ova consumption
(Fig. 1C). In a similar way to the humoral response, the peripheral
blood CD3+ CD4+, CD3+ CD8+ and CD3+ CD4+ CD25+ Foxp3+ cells of
sensitized mice were increased after 7 days of Ova diet ingestion in
comparison to Control group, with a signiﬁcant decrease after
14 days of continued antigen ingestion (Fig. 1D–F).
3.2. Serum levels of anti-Ova IgE and anti-mBSAIgG
Antigen-induced arthritis was induced by intra-dermally
immunization with mBSA in CFA, followed by injection of mBSA
into synovial cavity 14 days thereafter (Arthritis and Ova/Arthritis
groups); mice injected only with CFA (Control and Ova groups)
served as controls (Fig. 2A). The protocol of arthritis induction
did not interfere on anti-Ova IgE serum levels (Fig. 2B). On the
other hand, the anti-mBSAIgG levels induced by mBSA immuniza-
tion were totally abrogated in Ova sensitized mice after continuous
ingestion of Ova diet (Fig. 2C).
3.3. Cytokine and chemokine concentrations in periarticular tissue
An increased level of the inﬂammatory cytokines TNF-a, IL-1b,
and the chemokine CXCL-1 were found in periarticular tissue from
Arthritis group in comparison to Control group. Ova ingestion by
Ova immunized mice greatly reduced the concentration of TNF-a,
IL-1b, and the CXCL-1 in periarticular tissue induced by arthritis
protocol (Fig. 3A–C).
3.4. Leukocyte recruitment to periarticular tissue and knee synovial
cavity
Leukocyte recruitment to periarticular tissue was evaluated by
the visualization of leukocyte-endothelial cell interactions in thesynovial microcirculation and by histology of knee joint. As seen
in Fig. 4 and in the Supplementary video 1, AIA induced an increase
in leukocyte rolling (Fig. 4A) and adhesion (Fig. 4B) followed by
migration towards the tissue (Fig. 5B) and synovial cavity
(Fig. 6). Histological analysis of H&E-stained joint sections from
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dense inﬁltration of neutrophils in the synovium (Fig. 5B and E),
which was also conﬁrmed by the presence of activated MPO in per-
iarticular tissue (Fig. 5F). However, Ova/Arthritis group showed de-
creased number of adherent leukocytes in synovial
microcirculation (Fig. 4B and Supplementary video 2) and de-
creased neutrophil inﬁltration to the tissue (Fig. 5F) and to the
knee synovial cavity (Fig. 6B). The decreased neutrophil recruit-
ment was associated with reduced joint damage, as observed on
histopathological analysis (Fig. 5D).
In order to see whether only immunization with Ova could
interfere on leukocyte recruitment, a new set of experimental
groups were added to the study. As observed in Fig. 7A, the proto-
col of Ova sensitization, without further Ova ingestion, did not re-
duce the migration of leukocytes toward the knee synovial cavity.
Also, in order to see if there was an antigen competition in the mo-
ment of mBSA immunization and Ova ingestion, other two groups
were added. Both groups were sensitized with Ova on day 0 and
14. However, one of these groups was immunized with mBSA onFig. 5. Histological analysis and determination of MPO activity. BALB/c mice of Ova
and Ova/Arthritis groups were sensitized with ovalbumin (Ova) in Al(OH)3 on day 0
and with Ova on day 14. The Control and Arthritis groups received Al(OH)3 on day 0
and saline on day 14. On day 21, the Arthritis and Ova/Arthritis groups were
immunized with mBSA in Freund’s complete adjuvant (CFA) and the Control and
Ova groups received only an emulsion of saline in CFA. On the same day (day 21),
the standard mouse chow was replaced by Ova diet for all groups until the end of
experiment (day 36). On day 35, the Arthritis and Ova/Arthritis groups received an
injection of mBSA in saline in both knee joint while the Control and Ova groups
received only saline. On day 36, the right knee joint was collected for histological
analysis (A–E) and the left knee joint for MPO determination (F). The histological
slides were stained with hematoxylin-eosin and evaluated qualitatively. Scale bars
mean 100 lm (A–D) and 25 lm (E). Arrow indicates the leukocyte inﬁltration in
synovial cavity. Illustrative picture of the knee joint from Control group (A),
Arthritis group (B and E), Ova group (C) and Ova/Arthritis group (D). Values
represent the mean ± SEM. ⁄p < 0.05 compared to Control group. ⁄⁄p < 0.05 com-
pared to Arthritis group.
Fig. 4. Leukocyte recruitment to periarticular tissue and knee synovial cavity. BALB/
c mice of Ova and Ova/Arthritis groups were sensitized with ovalbumin (Ova) in
Al(OH)3 on day 0 and with Ova on day 14. The Control and Arthritis groups received
Al(OH)3 on day 0 and saline on day 14. On day 21, the Arthritis and Ova/Arthritis
groups were immunized with mBSA in Freund’s complete adjuvant (CFA) and the
Control and Ova groups received only an emulsion of saline in CFA. On the same day
(day 21), the standard mouse chow was replaced by Ova diet for all groups until the
end of experiment (day 36). On day 35, the Arthritis and Ova/Arthritis groups
received an injection of mBSA in saline in both knee joint while the Control and Ova
groups received only saline. On day 36, the leukocyte rolling (A) and adhesion (B) to
the synovial microcirculation were assayed by intravital microscopy. Values
represent the mean ± SEM. ⁄p < 0.05 compared to Control group. ⁄⁄p < 0.05 com-
pared to Arthritis group.day 21, was fed with Ova diet only for 24 h (day 21) and received
mBSA intra-articular on day 35. The other group was immunized
with mBSA on day 18, was fed with Ova diet only for from day
21–33, and received mBSA intra-articular on day 32. As shown in
Fig. 7B, the ingestion of Ova on day 21 for 24 h did not reduce
the antigen-induced leukocyte recruitment, discarding the occur-
rence of antigenic competition. Moreover, the continuous antigen
ingestion was able to reduce leukocyte recruitment to periarticular
tissue and cavity.4. Discussion
We demonstrated that following 24 hours of mBSA injection
into knee joint of immunized mice, an intense inﬂammatory inﬁl-
trate, predominantly neutrophilic, was observed. Also, higher lev-
els of TNF-a, IL-1b and CXCL-1 conﬁrmed a marked inﬂammatory
response. Interestingly, arthritic mice which were chronically fed
with antigen had reduced articular leukocyte inﬁltration and lower
serum levels of anti-mBSA IgG. Chronic ingestion of ovalbumin by
Ova sensitized animals induced transitory high levels of anti-OVA
Fig. 7. Interference of immunization and different times of challenge with
ovalbumin in the recruitment of leucocytes to the synovial cavity. BALB/c mice
were separated in groups and submitted to different experimental protocols as
speciﬁed in the ﬁgures. The Ova sensitized groups received the antigen in Al(OH)3
on day 0 and only the antigen on day 14. For some groups, the standard chow was
replaced by Ova diet only on day 21, on days 21–33 or on days 21–36. On day 18 or
21, the Arthritis group was immunized with mBSA in Freund’s complete adjuvant
(CFA) and the Control group received only an emulsion of saline in CFA. On day 32
or 35, the Arthritis group received an injection of mBSA in saline in both knee joint
while the Control group received only saline. On day 33 or 36, the cavity of the left
knee was washed and number of total leucocytes was counted. Values represent the
mean ± SEM. ⁄p < 0.05 compared to Control group. ⁄⁄p < 0.05 compared to Arthritis
group.
Fig. 6. Leucocytes in the synovial cavity. BALB/c mice of Ova and Ova/Arthritis
groups were sensitized with ovalbumin (Ova) in Al(OH)3 on day 0 and with OVA on
day 14. The Control and Arthritis groups received Al(OH)3 on day 0 and saline on
day 14. On day 21, the Arthritis and Ova/Arthritis groups were immunized with
mBSA in Freund’s complete adjuvant (CFA) and the Control and Ova groups received
only an emulsion of saline in CFA. On the same day (day 21), the standard mouse
chow was replaced by Ova diet for all groups until the end of experiment (day 36).
On day 35, the Arthritis and Ova/Arthritis groups received an injection of mBSA in
saline in both knee joint while the Control and Ova groups received only saline. On
day 36, the cavity of the left knee was washed and number of total leucocytes (A),
neutrophils (B) and mononuclear cells (C) was counted. Values represent the
mean ± SEM. ⁄p < 0.05 compared to Control group. ⁄⁄p < 0.05 compared to Arthritis
group.
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creased after fourteen days, suggesting that a continuous feeding
may induce oral tolerance to Ova [25]. Moreover, the prolonged
ingestion of antigen after sensitization also showed anti-inﬂamma-
tory effects on cellular as well as humoral events triggered in ani-
mals with arthritis induced by an unrelated antigen.
As primed (immunized) organisms are resistant to oral toler-
ance induction, its therapeutic use might be challenging. In thiscase, oral exposures may actually induce secondary (booster) re-
sponses and anaphylactic reactions [26,27]. However, therapeutic
application of oral tolerance in allergic diseases has gained increas-
ing attention. In clinical trials, oral immunotherapy (OIT) and sub-
lingual immunotherapy (SLIT) involving oral administration of
allergenic foods have been applied as an allergen-speciﬁc immuno-
therapy for persistent food allergies [27–30]. Proposed mecha-
nisms to explain oral tolerance include active suppression by
regulatory T cells and clonal energy/deletion of lymphocytes in
gut-associated lymphoid tissue [27]. In this sense, it was demon-
strated that antigen-experienced CD4+ T cells do not acquire regu-
latory phenotype, neither become anergic or undergo to an
immune deviation, but die by apoptosis within the liver [31], con-
tributing to antigen-speciﬁc systemic unresponsiveness upon oral
antigen uptake. Also, the oral route favors a robust stabilization
of speciﬁc antibody formation and may occur at low, medium or
high serum antibody levels [32].
Our work not only demonstrated that the prolonged ingestion
of antigen after immunization reduced speciﬁc IgE levels and
speciﬁc blood T cells, but also showed anti-inﬂammatory effects
on cellular as well as humoral events to unrelated antigen. Accord-
ing to these ﬁndings, we demonstrated that production of anti-
mBSA IgG by animals immunized and fed with Ova diet was almost
M.d.L.M. Noviello et al. / Cellular Immunology 284 (2013) 20–28 27completely suppressed. Additionally, reduced cytokine production
and leukocyte recruitment to the tissue were concomitantly ob-
served, which might be a result of decreased expression of adhe-
sion molecules and chemokine release. Also, in turn, the reduced
inﬂux of neutrophils could decrease the local production of cyto-
kines [33].
The previously indirect effect of oral tolerance described is a
possible way to explain our results. Indeed, it has been demon-
strated that the contact with a protein by oral route several days
before an immunization containing adjuvant with the same pro-
tein and another unrelated antigen is able to block the formation
of antibodies to this unrelated antigen. As a consequence, it re-
duces drastically the formation of granulomas around Schistosoma
mansoni eggs, affects the eosinophil production in bone marrow
and improves wound healing in skin. We can suggest, similarly
to these authors, that it is much more general than suggested by
innocent bystander suppression hypothesis, phenomenon in which
regulatory cells and immunosuppressive cytokines activated by
feeding suppress immune response in their vicinity [34–37]. How-
ever, contrary to our results Yoshino and Inada et al., using as oral
treatment mBSA and Ova protein, during ﬁve days after immuniza-
tion, failed to inhibit the establishment of synovial inﬂammation in
antigen-induced arthritis [21,38].This discrepancy may be attrib-
uted to the differences in the experimental animals and to the
ingestion time of protein, considering that until the seventh day
of Ova ingestion diet we did not observed reduced anti-Ova IgE lev-
els in the serum of immunized animals.
It has been previously suggested that maintaining a balanced
peripheral immune system may not be the only responsibility of
a specialized subset of T cells dedicated to immune suppression,
but rather a side effect of normal competition for shared resources
within an intact immune system [39]. From this premises, we also
investigated the suppressive effect of antigenic competition during
immunization with mBSA by using two additional experimental
groups. In one group, the immunization with mBSA was performed
4 days before the Ova diet consumption and we could observe that
the cellular and humoral parameters of inﬂammation were similar
to the Ova/Arthritis group. In another group, the ingestion of Ova
was conducted only for 24 h on day 21, which did not interfere
with the induction of arthritis, conﬁrming that a continuous inges-
tion of antigen is necessary.
Although the phenomenon of oral tolerance needs to be clari-
ﬁed, in spite of intense basic and clinical research [27,29], impor-
tant observations of our group have shown that chronic
restricted and voluntary ingestion of the speciﬁc antigen by previ-
ously immunized animals, in addition to provoke mild inﬂamma-
tion in the gut [40], is able to suppress airway inﬂammation [41].
The oral tolerance and its indirect effects could explain the de-
creased levels of anti-Ova IgE in the serum and speciﬁc blood T
cells of immunized mice after fourteen days of Ova diet consump-
tion and its consequent impact on a non related pathological con-
dition such as antigen-induced arthritis [32,34,35].
5. Conclusion
Our work, in addition to present a model to study the induction
of oral tolerance in animals previously immunized, enables us to
make important observations, that can be useful for future studies
about the application of oral immunotherapy in allergic patients
and new therapies for rheumatoid arthritis.
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